RESUMO
A structural, profile-based algorithm was used to identify interleukin 20 (IL-20), a novel IL-10 homolog. Chromosomal localization of IL-20 led to the discovery of an IL-10 family cytokine cluster. Overexpression of IL-20 in transgenic (TG) mice causes neonatal lethality with skin abnormalities including aberrant epidermal differentiation. Recombinant IL-20 protein stimulates a signal transduction pathway through STAT3 in a keratinocyte cell line, demonstrating a direct action of this ligand. An IL-20 receptor was identified as a heterodimer of two orphan class II cytokine receptor subunits. Both receptor subunits are expressed in skin and are dramatically upregulated in psoriatic skin. Taken together, these results demonstrate a role in epidermal function and psoriasis for IL-20, a novel cytokine identified solely by bioinformatics analysis.
Assuntos
Epiderme/imunologia , Interleucinas/genética , Receptores de Citocinas/genética , Receptores de Citocinas/imunologia , Animais , Linhagem Celular , Mapeamento Cromossômico , Clonagem Molecular , Proteínas de Ligação a DNA/metabolismo , Dimerização , Epiderme/química , Epiderme/patologia , Expressão Gênica/imunologia , Humanos , Interleucina-10/genética , Interleucina-10/imunologia , Interleucinas/química , Interleucinas/imunologia , Queratinócitos/citologia , Queratinócitos/imunologia , Queratinas/genética , Camundongos , Camundongos Transgênicos , Dados de Sequência Molecular , Psoríase/imunologia , Psoríase/patologia , Receptores de Citocinas/química , Fator de Transcrição STAT3 , Homologia de Sequência de Aminoácidos , Transativadores/metabolismo , Regulação para Cima/imunologiaRESUMO
Intravenous thrombolysis has become a primary mode of reperfusion therapy for selected patients with acute myocardial infarction. The timing and potential benefits of cardiac angiography and coronary revascularization after thrombolysis in patients experiencing an uncomplicated myocardial infarction have been extensively studied, but remain clinically controversial. This review discusses the potential benefits and timing of acute and convalescent phase cardiac catheterization after thrombolytic therapy in patients with acute myocardial infarction.